Results 171 to 180 of about 12,991 (277)
What's new? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel +21 more
wiley +1 more source
Crossed Erythrocytes Agglutination Pattern Observed in a Patient With Hereditary Elliptocytosis. [PDF]
Melo MAW +3 more
europepmc +1 more source
Carbohydrate‐Based Drug Discovery: Synthetic Strategies and Clinical Applications
The picture depicts the molecules discussed in the review. On the left side, the general scaffold of sugars is shown. Next to it are four carbohydrate‐based molecules, including remdesivir, islatravir, empagliflozin, and Globo‐H. Remdesivir and islatravir contain a substituted ribose ring attached to a modified nucleobase.
Stephan Scheeff +2 more
wiley +1 more source
Alport Syndrome: A Specific Case of Hereditary Nephropathy
Cohan Eric
doaj
A rare case of dual glomerular pathology: Alport syndrome and immune complex-mediated MPGN. [PDF]
Ozcan SG +6 more
europepmc +1 more source
Clinical features of hearing loss and genotype-phenotype correlations in Alport syndrome caused by COL4A4 or COL4A5 variants. [PDF]
Matsuzaki S +10 more
europepmc +1 more source
The immunomodulatory potential of bradykinin signaling in autoimmune conditions. [PDF]
Szaryńska M, Olejniczak-Kęder A.
europepmc +1 more source

